Effects of Increased, Egg-Based Protein Intake on Muscle Composition,
S25
1 other identifier
observational
22
1 country
1
Brief Summary
This study is designed to assess the effect of a diet-controlled nutrition program utilizing an egg-based higher protein diet on muscle composition and size, and indices of metabolic health and markers of systemic inflammation in older men and women who are slightly overweight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 11, 2011
CompletedFirst Posted
Study publicly available on registry
July 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedFebruary 4, 2016
May 1, 2013
3 years
February 11, 2011
February 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects of Increased, Egg-Based Protein Intake on Muscle Composition, Metabolic Health and Systemic Inflammation in Obese, Older Adults
Anticipated subject recruitment completion
December 31, 2013
Study Arms (1)
High or Normal Dietary Protein Intake
Interventions
Dietary Protein Intake This is a 12-week randomized,prospective study incorporating a dietary intervention in which subjects will consume either higher protein(HP:1.4g protein•kg-1•d-1) or normal protein diet (NP:.8g protein•kg-1•d-1)
Eligibility Criteria
Men and Women between the ages of 65-80
You may qualify if:
- Men and Women between the ages of 55-80
- Body Mass Index between 27-35
- Non Diabetic
- Normal liver, kidney and heart functions within 10% of clinical normalcy
- Not currently following a weight loss or other special /non balanced diets
- weight stable
You may not qualify if:
- fasting glucose \> 110 mg/dl
- blood pressure \> 160/110 mm Hg
- plasma total cholesterol \> 260 mg/dl
- LDL-cholesterol \>160mg/dl
- triacylglycerol\>400 mg/dl
- \>than 1 hour/week of habitual aerobic and /or resistance exercise
- Currently taking prescribed blood thinners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Purdue University
West Lafayette, Indiana, 47907, United States
Biospecimen
whole blood, serum, and muscle tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wayne W Campbell, Ph.D.
Purdue University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Wayne Campbell, Ph.D
Study Record Dates
First Submitted
February 11, 2011
First Posted
July 19, 2011
Study Start
February 1, 2011
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
February 4, 2016
Record last verified: 2013-05